|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 17, 2006 J. Lipid Res., doi:10.1194/jlr.M500449-JLR200
Dept of Medicine, University of Medicine & Dentistry of New Jersey, NJ Medical School, East Orange, NJ 07018-1095
Corresponding Author: xugu{at}umdnj.edu
The transcription of CYP7A1, whose gene product is the rate limiting enzyme for bile acid biosynthesis, a major cholesterol catabolic pathway, is greatly decreased in cholesterol fed rabbits. To determine whether the molecular structure of the promoter is responsible for this down-regulation, we cloned the rabbit CYP7A1 promoter, and studied the effects of a-fetoprotein transcription factor (FTF), liver X receptor (LXRa), short heterodimer partner (SHP) and cholesterol on its transcription. A 1.1 kb 5-flanking region of rabbit CYP7A1 (promoter) was cloned, and putative binding sites for FTF and LXR were identified. Gel shift assays demonstrated that these sites specifically bound FTF and LXRa/RXR, respectively. Adding LXRa/RXR, together with their ligands (L/R), to the promoter transfected into HepG2 cells greatly increased its activity. When the LXR binding site was mutated, baseline promoter activity was abolished and the stimulatory effect of L/R was absent. FTF did not increase the promoter activity, nor did it enhance the stimulatory effect of L/R. Mutating the FTF binding site also abolished the promoter baseline activity. Adding increasing amounts of SHP abolished the stimulatory effect of L/R and FTF enforced the effect of SHP to decrease promoter activity below baseline levels. Comparison studies showed that rabbit and rat CYP7A1 promoter respond similarly to L/R, FTF and SHP. And, cholesterol did not repress either rabbit or rat CYP7A1 promoter activity. Thus, down regulation of CYP7A1 in cholesterol-fed rabbits is due secondarily to the activation of FXR which increases SHP expression to override the positive effects of LXRa. Although FTF is a competent factor for maintaining baseline activity, it does not further enhance but may suppress CYP7A1 transcription.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||